JP2006508134A5 - - Google Patents

Download PDF

Info

Publication number
JP2006508134A5
JP2006508134A5 JP2004552010A JP2004552010A JP2006508134A5 JP 2006508134 A5 JP2006508134 A5 JP 2006508134A5 JP 2004552010 A JP2004552010 A JP 2004552010A JP 2004552010 A JP2004552010 A JP 2004552010A JP 2006508134 A5 JP2006508134 A5 JP 2006508134A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
oxathiolan
deoxythymidine
azido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004552010A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006508134A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/035830 external-priority patent/WO2004043433A2/en
Publication of JP2006508134A publication Critical patent/JP2006508134A/ja
Publication of JP2006508134A5 publication Critical patent/JP2006508134A5/ja
Pending legal-status Critical Current

Links

JP2004552010A 2002-11-08 2003-11-07 医薬組成物 Pending JP2006508134A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42518202P 2002-11-08 2002-11-08
PCT/US2003/035830 WO2004043433A2 (en) 2002-11-08 2003-11-07 Pharmaceutical antiviral compositions

Publications (2)

Publication Number Publication Date
JP2006508134A JP2006508134A (ja) 2006-03-09
JP2006508134A5 true JP2006508134A5 (https=) 2006-12-21

Family

ID=32312939

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004552010A Pending JP2006508134A (ja) 2002-11-08 2003-11-07 医薬組成物

Country Status (9)

Country Link
US (1) US20050287177A1 (https=)
EP (1) EP1567133B1 (https=)
JP (1) JP2006508134A (https=)
AT (1) ATE361059T1 (https=)
AU (1) AU2003291457A1 (https=)
CA (1) CA2505130C (https=)
DE (1) DE60313657T2 (https=)
ES (1) ES2286471T3 (https=)
WO (1) WO2004043433A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
ES2320663T3 (es) 2003-08-26 2009-05-27 Smithkline Beecham Corporation Nuevos indoles cicloalquil(b) condensados.
TW201414495A (zh) 2005-04-04 2014-04-16 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
RU2008128424A (ru) * 2005-12-14 2010-01-20 Сипла Лимитед (In) Фармацевтическая комбинация, включающая нуклеотидный и нуклеозидный ингибиторы обратной транскриптазы (такие как тенофовир и ламивудин) в различных частях дозы
PT1981506E (pt) 2006-01-20 2013-06-25 Janssen R & D Ireland Tratamento a longo prazo da infeção pelo vih com tmc278
AR065720A1 (es) 2007-03-14 2009-06-24 Tibotec Pharm Ltd Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
JP2010529073A (ja) * 2007-06-06 2010-08-26 ビーエーエスエフ ソシエタス・ヨーロピア チュアブル錠及びトローチ剤製造のための医薬製剤
MX2009013063A (es) * 2007-06-06 2010-01-15 Basf Se Formulacion farmaceutica para la produccion de tabletas de desintegracion rapida.
MX2009013499A (es) * 2007-06-22 2010-01-18 Bristol Myers Squibb Co Composiciones comprimidas que contienen atazanavir.
KR101057640B1 (ko) * 2009-05-27 2011-08-18 (주)다산메디켐 발포성 층을 포함하는 다층 정제

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
WO1992020344A1 (en) * 1991-05-16 1992-11-26 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
GB9111902D0 (en) * 1991-06-03 1991-07-24 Glaxo Group Ltd Chemical compounds
US6177435B1 (en) * 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
ATE186544T1 (de) * 1992-08-04 1999-11-15 James M Dunn Pharmazeutische formulierungen mit kontrollierter freigabe von 3'-azido-3'-deoxythymidin und verfahren zur verwendung
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof

Similar Documents

Publication Publication Date Title
WO2009008006A3 (en) Pharmaceutical compositions for gastrointestinal drug delivery
JP2006508134A5 (https=)
CN103096881A (zh) 含有具有不愉快味道的药物的膜制剂
JP2009510171A5 (https=)
JP2007523091A5 (https=)
ATE350040T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin
JP2009541443A5 (https=)
JP2012502015A5 (https=)
JP2007145875A5 (https=)
WO2004064815A8 (en) Oral dosage formulation
RU2009110452A (ru) Галеновые составы алискирена
JP2009143964A5 (https=)
JP2010512414A5 (https=)
JP2017519019A5 (https=)
PE20081106A1 (es) Comprimidos pediatricos de capecitabina
NO20091644L (no) Hurtig desintegrerende, lyofiliserte orale formuleringer av en trombinreseptorantagonist
JP2009519311A5 (https=)
TW200635617A (en) Multiparticulate pharmaceutical form comprising mucoadhesively formulated nucleic acid active ingredients, and a process for producing the pharmaceutical form
JP2008536853A5 (https=)
MX2010007281A (es) Composiciones farmaceuticas de amlodipina y valsartan.
AR066924A1 (es) Formulacion de nevirapina de liberacion prolongada
JP2009517411A5 (https=)
JP2008536931A5 (https=)
JP2008515980A5 (https=)
CA2505130A1 (en) Pharmaceutical compositions